| Therapeutic potential of ginseng in the management of cardiovascular disorders. | |
| | |
MedLine Citation:
|
PMID: 21985167 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Although employed in Asian societies for thousands of years, the use of ginseng as an herbal medication for a variety of disorders has increased tremendously worldwide in recent years. Ginseng belongs to the genus Panax, of which there exists a variety, generally reflecting their geographic origin. North American ginseng (Panax quinquefolius) and Asian ginseng (Panax ginseng) are two such varieties possessing a plethora of pharmacological properties, which are attributed primarily to the presence of different ginsenosides that bestow these ginsengs with distinct pharmacodynamic profiles. The many cardiovascular benefits attributed to ginseng include cardioprotection, antihypertensive effects, and attenuation of myocardial hypertrophy and heart failure. Experimental studies have revealed a number of beneficial properties of ginseng, particularly in the area of cardiac protection, where ginseng and ginsenosides have been shown to protect the ischaemic and reperfused heart in a variety of experimental models. Emerging evidence also suggests that ginseng attenuates myocardial hypertrophy, thus blunting the remodelling and heart failure processes. However, clinical evidence of efficacy is not convincing, likely owing primarily to the paucity of well designed, randomized, controlled clinical trials. Adding to the complexity in understanding the cardiovascular effects of ginseng is the fact that each of the different ginseng varieties possesses distinct cardiovascular properties, as a result of their respective ginsenoside composition, rendering it difficult to assign a general, common cardiovascular effect to ginseng. Additional challenges include the identification of mechanisms (likely multifaceted) that account for the effects of ginseng and determining which ginsenoside(s) mediate these cardiovascular properties. These concerns notwithstanding, the potential cardiovascular benefit of ginseng is worthy of further studies in view of its possible development as a cardiovascular therapeutic agent, particularly as adjunctive therapy to existing medications. |
| | |
Authors:
|
Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan |
Related Documents
:
|
20494597 - Associations between cardiac pathology and clinical, echocardiographic and electrocardi... 983957 - Coronary arterial reperfusion. iii. early and late effects on regional myocardial funct... 12388287 - Role of mmps and plasminogen activators in angiogenesis after transmyocardial laser rev... 655087 - The effect of chronic cardiac denervation on infarct size following acute coronary occl... 16162767 - Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coro... 11206757 - Harvested porcine mitral xenograft fixation: impact on fluid dynamic performance. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Drugs Volume: 71 ISSN: 0012-6667 ISO Abbreviation: Drugs Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7600076 Medline TA: Drugs Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 1989-2008 Citation Subset: IM |
Affiliation:
|
Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
Next Document: Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneo...